WOONSOCKET, R.I., Jan. 12, 2023 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Sam Khichi will join the company as Executive Vice President, Chief Policy Officer and General Counsel, effective February 13. He will lead the legal, compliance, and government affairs teams who support CVS Health's strategy to make health care more accessible and affordable, leading to better health outcomes for all.
"Sam brings diversified experience to many key issues for CVS Health, including geopolitical matters, data privacy, and compliance," said CVS Health President and CEO Karen S. Lynch. "He has an exceptional track record of managing complex health care business and legal strategies."
Khichi will become a member of the company's executive leadership team and report to Lynch. Prior to joining CVS Health, he served at Becton Dickinson as Executive Vice President, Corporate Development, Public Policy, Regulatory Affairs and General Counsel. He joined Becton Dickinson through the acquisition of C. R. Bard where he served as Senior Vice President, General Counsel and Secretary, and previously was the Chief Administrative Officer, Senior Vice President and General Counsel at Catalent Pharma Solutions. Khichi has led significant transformations at complex and large-scale health care organizations.
"This is an exciting time to join CVS Health and be part of a team whose strategy is redefining how health care is delivered in this country," Khichi said. "I have long admired CVS Health for its innovation and leadership in advancing the consumer health care experience. Achieving transformation of this scale requires changing the way information is shared and technology utilized by consumers, employers, and providers and CVS Health is uniquely positioned to lead this change."
Khichi succeeds Tom Moriarty, who plans to retire in April. Moriarty has played a critical role in many significant CVS Health moments, from the company's industry-leading role during the COVID-19 pandemic to helping lead transformative health care acquisitions.
About CVS Health
CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.
Media contact
T.J. Crawford
212-457-0583
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor contact
Larry McGrath
800-201-0938
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$44.36 |
Daily Change: | 0.58 1.32 |
Daily Volume: | 18,754,397 |
Market Cap: | US$55.890B |
November 19, 2024 November 18, 2024 November 06, 2024 November 06, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB